Welcome to our dedicated page for Mgp Ingredients SEC filings (Ticker: MGPI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MGP Ingredients, Inc. filings document an operating company with three reported segments: Branded Spirits, Distilling Solutions and Ingredient Solutions. Its 8-K reports furnish quarterly and annual results, financial outlook updates, dividend declarations, production and facility disclosures, and leadership or compensation-related changes.
The company’s proxy and governance filings cover board structure, director elections, executive compensation, equity awards, bylaw amendments and voting rights tied to common and preferred stock. These records also describe the governance framework for Group A and Group B directors and the capital-structure provisions that affect director vacancies and written consents.
MGP Ingredients reported weak fourth-quarter and full-year 2025 results driven by a large non-cash impairment and sharp volume declines in whiskey and ingredients. Full-year sales fell 24% to $536.4M, while gross profit dropped 30% to $199.4M and adjusted EBITDA declined 41% to $116.0M.
The company recorded a $152.6M goodwill and intangible impairment in Branded Spirits, pushing 2025 net income to a loss of $107.8M and basic EPS to $4.99 loss, though adjusted EPS was $2.85. Distilling Solutions revenue fell 45% as customers reduced brown-goods purchases, and Ingredient Solutions margins were hurt by equipment outages and higher waste costs.
Despite lower earnings, operating cash flow reached a record $121.5M, net debt leverage was 2.0x, and capex was cut 56% to $31.9M. For 2026, MGP guides sales to $480–$500M, adjusted EBITDA to $90–$98M, adjusted EPS to $1.50–$1.80, and capex around $20M.
MGP Ingredients reported weak fourth-quarter and full-year 2025 results driven by a large non-cash impairment and sharp volume declines in whiskey and ingredients. Full-year sales fell 24% to $536.4M, while gross profit dropped 30% to $199.4M and adjusted EBITDA declined 41% to $116.0M.
The company recorded a $152.6M goodwill and intangible impairment in Branded Spirits, pushing 2025 net income to a loss of $107.8M and basic EPS to $4.99 loss, though adjusted EPS was $2.85. Distilling Solutions revenue fell 45% as customers reduced brown-goods purchases, and Ingredient Solutions margins were hurt by equipment outages and higher waste costs.
Despite lower earnings, operating cash flow reached a record $121.5M, net debt leverage was 2.0x, and capex was cut 56% to $31.9M. For 2026, MGP guides sales to $480–$500M, adjusted EBITDA to $90–$98M, adjusted EPS to $1.50–$1.80, and capex around $20M.
MGP Ingredients, Inc. filed a post-effective amendment registering 4,585,970 shares of its common stock for resale. The filing adds a resale prospectus to the Form S-3ASR to cover up to 4,585,970 shares held by former HoldCo stockholders in connection with the 2021 Merger.
The prospectus states the Company will not receive proceeds from these sales and that the selling stockholders may sell on Nasdaq or in negotiated transactions. Examples shown include Luxco 2017 Irrevocable Trust 1,513,771 and Ann S. Lux 2005 Irrevocable Trust FBO Donn S. Lux 771,688. Shares outstanding were 21,363,225 as of February 20, 2026.
MGP Ingredients CFO Brandon Gall reported a tax-related share disposition. On the reported date, he disposed of 598 shares of common stock at $25.93 per share in a transaction coded as a tax-withholding disposition. After this transaction, he directly owned 51,612 equity-linked interests, consisting of 31,423 shares of common stock and 20,189 restricted stock units, as noted in the footnote.
MGP Ingredients Inc. Chief Human Resources Officer Erika Lapish reported a tax-related share disposition. On February 20, 2026, she disposed of 241 shares of common stock at $25.93 per share to satisfy tax withholding obligations, a non-open-market transaction coded as a tax-withholding disposition. After this, she directly holds 9,121 shares, which the footnote states represent 6,131 common shares and 2,990 restricted stock units, and she also reports 550 shares held indirectly by her husband.
MGP Ingredients Inc. Chief Commercial Officer Amel Pasagic reported a Form 4 transaction involving company common stock. He disposed of 346 shares of common stock at $25.93 per share in a tax-withholding disposition related to payment of tax liability. Following this transaction, his directly held position is reported as 10,487 shares, which the footnote explains consists of 6,864 shares of common stock and 3,623 restricted stock units.
MGP Ingredients CFO Brandon Gall reported two tax-related share dispositions under a Form 4. On February 14, 2026, he used 1,558 shares of common stock at $25.74 per share to cover tax withholding, and on February 16, 2026, he used another 2,438 shares at the same price for the same purpose. These are coded as tax-withholding dispositions, not open-market purchases or sales. Footnotes state that his holdings include combinations of common stock and restricted stock units.
MGP Ingredients chief human resources officer Erika Lapish reported Form 4 insider transactions showing share dispositions used to cover tax obligations. She delivered 1,211 shares of common stock on February 16 and 554 shares on February 14 at $25.74 per share as tax-withholding dispositions. After these transactions, she directly owned 9,362 common shares, and footnotes indicate her holdings also include restricted stock units.
MGP Ingredients Chief Commercial Officer Amel Pasagic reported two tax-related share dispositions. On February 16, he delivered 1,527 shares of common stock at $25.74 per share to satisfy tax obligations tied to equity compensation. On February 14, he similarly delivered 744 shares at the same price for tax withholding, rather than selling shares in the open market.
Footnotes explain that his reported holdings at different times consisted of combinations of common stock and restricted stock units, including 4,114 shares and 8,246 restricted stock units in one instance and 6,278 shares and 4,555 restricted stock units in another.
MGP Ingredients, Inc. reported leadership changes following a board-approved reorganization of certain roles. The company stated that the employment of Chief Human Resources Officer Erika Lapish and Chief Commercial Officer Amel Pasagic will conclude on February 20, 2026.
Both executives are eligible for severance payments under the company’s Executive Severance Plan, conditioned on signing a release and agreeing to post-employment covenants. The filing does not describe changes to other executive positions or provide financial details related to the reorganization beyond the severance eligibility.
BlackRock, Inc. filed Amendment No. 10 to report its beneficial ownership of 1,067,363 shares of MGP INGREDIENTS INC common stock, representing 5.01% of the class as of 12/31/2025. BlackRock reports sole power to vote 1,034,539 shares and sole power to dispose of 1,067,363 shares, with no shared voting or dispositive power.
The filing states that various persons have the right to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares. BlackRock certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of MGP Ingredients.
BlackRock, Inc. filed Amendment No. 10 to report its beneficial ownership of 1,067,363 shares of MGP INGREDIENTS INC common stock, representing 5.01% of the class as of 12/31/2025. BlackRock reports sole power to vote 1,034,539 shares and sole power to dispose of 1,067,363 shares, with no shared voting or dispositive power.
The filing states that various persons have the right to receive dividends or sale proceeds from these shares, but no single person has more than five percent of the total outstanding common shares. BlackRock certifies the holdings are in the ordinary course of business and not for the purpose of changing or influencing control of MGP Ingredients.